INZY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.19%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $52,209.62

Inozyme Pharma Insider Trading History Chart

Inozyme Pharma Share Price & Price History

^$0.88

▼ -0.034 (-3.74%)

As of 04/1/2025 04:17 PM ET

Days: 30 | 90 | 365

Inozyme Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2024	Douglas A Treco	CEO	Sell	7,523	$6.94	$52,209.62	20,665
8/1/2023	Pivotal Bioventure Partners Fu	Director	Buy	833,333	$4.80	$3,999,998.40	2,923,110
5/11/2023	Robert Lorne Hopfner	Director	Buy	219,230	$6.48	$1,420,610.40	3,432,816
3/29/2023	Robert Lorne Hopfner	Director	Buy	344,592	$4.54	$1,564,447.68	3,213,586
3/27/2023	Robert Lorne Hopfner	Director	Buy	51,074	$3.70	$188,973.80	2,712,228
12/15/2022	Henric Bjorn Bjarke	COO	Buy	21,500	$1.39	$29,885.00	105,441
4/19/2022	Axel Bolte	CEO	Buy	67,750	$3.69	$249,997.50	258,575
4/19/2022	Henric Bjorn Bjarke	COO	Buy	27,100	$3.69	$99,999.00	80,626
4/19/2022	Longitude Capital Partners Iii	Major Shareholder	Buy	1,355,000	$3.69	$4,999,950.00	4,174,379
4/19/2022	Robert Lorne Hopfner	Director	Buy	1,070,000	$3.69	$3,948,300.00	2,661,154

SEC Filings (Institutional Ownership Changes) for Inozyme Pharma (NASDAQ:INZY)

88.30% of Inozyme Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inozyme Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	200,336	$0.56M	0.0%	-23.2%	0.312%
2/17/2025	Two Sigma Investments LP	31,924	$88K	0.0%	N/A	0.050%
2/17/2025	Two Sigma Advisers LP	78,700	$0.22M	0.0%	+223.9%	0.123%
2/17/2025	Sanofi	443,255	$1.23M	0.7%	N/A	0.690%
2/17/2025	Shay Capital LLC	53,588	$0.15M	0.0%	N/A	0.083%
2/17/2025	ProShare Advisors LLC	17,807	$49K	0.0%	N/A	0.028%
2/17/2025	Nuveen Asset Management LLC	250,229	$0.69M	0.0%	+23.4%	0.390%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	201,232	$0.56M	0.0%	-11.1%	0.313%
2/17/2025	Millennium Management LLC	1,882,274	$5.21M	0.0%	+7.9%	2.930%
2/17/2025	Jacobs Levy Equity Management Inc.	129,749	$0.36M	0.0%	N/A	0.202%
2/17/2025	Graham Capital Management L.P.	12,044	$33K	0.0%	N/A	0.019%
2/17/2025	Deutsche Bank AG	40,215	$0.11M	0.0%	+29.1%	0.063%
2/17/2025	D. E. Shaw & Co. Inc.	17,813	$49K	0.0%	N/A	0.028%
2/17/2025	Cubist Systematic Strategies LLC	83,919	$0.23M	0.0%	N/A	0.131%
2/17/2025	Bank of America Corp DE	104,353	$0.29M	0.0%	-14.2%	0.162%
2/17/2025	Algert Global LLC	39,115	$0.11M	0.0%	N/A	0.061%
2/14/2025	Northern Trust Corp	450,764	$1.25M	0.0%	+2.7%	0.702%
2/14/2025	Susquehanna Fundamental Investments LLC	62,886	$0.17M	0.0%	N/A	0.098%
2/14/2025	Blue Owl Capital Holdings LP	1,080,027	$2.99M	0.7%	-3.6%	1.681%
2/14/2025	Adage Capital Partners GP L.L.C.	5,160,000	$14.29M	0.0%	-9.1%	8.032%
2/14/2025	Harvest Investment Services LLC	11,155	$31K	0.0%	N/A	0.017%
2/14/2025	Rock Springs Capital Management LP	3,861,983	$10.70M	0.4%	+1.6%	6.012%
2/14/2025	OneDigital Investment Advisors LLC	51,000	$0.14M	0.0%	+155.0%	0.079%
2/14/2025	Dimensional Fund Advisors LP	504,670	$1.40M	0.0%	+13.1%	0.786%
2/13/2025	Affinity Asset Advisors LLC	3,972,318	$11M	1.5%	+40.7%	6.184%
2/13/2025	Jump Financial LLC	89,291	$0.25M	0.0%	N/A	0.139%
2/13/2025	Walleye Capital LLC	237,620	$0.66M	0.0%	N/A	0.370%
2/13/2025	XTX Topco Ltd	31,737	$88K	0.0%	N/A	0.049%
2/13/2025	Barclays PLC	91,634	$0.25M	0.0%	+19.4%	0.143%
2/13/2025	Raymond James Financial Inc.	74,165	$0.21M	0.0%	N/A	0.115%
2/13/2025	Renaissance Technologies LLC	421,399	$1.17M	0.0%	+155.7%	0.656%
2/13/2025	ADAR1 Capital Management LLC	76,299	$0.21M	0.0%	N/A	0.119%
2/12/2025	Knott David M Jr	695,000	$1.93M	0.7%	+23.1%	1.082%
2/12/2025	Geode Capital Management LLC	1,179,622	$3.27M	0.0%	+0.7%	1.836%
2/12/2025	Wellington Management Group LLP	200,336	$0.56M	0.0%	-23.2%	0.312%
2/12/2025	BIT Capital GmbH	63,799	$0.18M	0.0%	N/A	0.099%
2/12/2025	JPMorgan Chase & Co.	128,872	$0.36M	0.0%	+345.5%	0.201%
2/11/2025	American Century Companies Inc.	79,349	$0.22M	0.0%	+11.6%	0.124%
2/11/2025	Intech Investment Management LLC	24,587	$68K	0.0%	N/A	0.038%
2/6/2025	Raymond James Financial Inc.	74,165	$0.21M	0.0%	N/A	0.115%
1/30/2025	Palumbo Wealth Management LLC	23,281	$64K	0.0%	+52.3%	0.036%
1/24/2025	abrdn plc	170,522	$0.47M	0.0%	N/A	0.265%
1/24/2025	China Universal Asset Management Co. Ltd.	13,621	$38K	0.0%	N/A	0.021%
12/26/2024	JPMorgan Chase & Co.	28,928	$0.15M	0.0%	+31.0%	0.045%
11/20/2024	Virtu Financial LLC	12,309	$64K	0.0%	N/A	0.019%
11/19/2024	Barclays PLC	76,730	$0.40M	0.0%	+261.4%	0.119%
11/16/2024	Geode Capital Management LLC	1,171,172	$6.13M	0.0%	+1.7%	1.823%
11/15/2024	Barclays PLC	76,730	$0.40M	0.0%	+261.4%	0.119%
11/15/2024	Jane Street Group LLC	49,460	$0.26M	0.0%	+7.5%	0.077%
11/15/2024	Wellington Management Group LLP	260,719	$1.36M	0.0%	+11.9%	0.406%
11/15/2024	Sphera Funds Management LTD.	1,191,140	$6.23M	1.0%	-18.6%	1.854%
11/15/2024	State Street Corp	1,050,420	$5.49M	0.0%	+5.0%	1.635%
11/15/2024	Readystate Asset Management LP	19,049	$100K	0.0%	N/A	0.030%
11/14/2024	Eventide Asset Management LLC	4,134,436	$21.62M	0.4%	+5.0%	6.436%
11/6/2024	OneDigital Investment Advisors LLC	20,000	$0.11M	0.0%	+51.5%	0.032%
11/5/2024	GSA Capital Partners LLP	35,402	$0.19M	0.0%	-13.5%	0.056%
10/23/2024	Values First Advisors Inc.	14,695	$77K	0.0%	-13.9%	0.024%
10/3/2024	SG Americas Securities LLC	15,457	$81K	0.0%	N/A	0.025%
9/16/2024	Cubist Systematic Strategies LLC	18,891	$84K	0.0%	N/A	0.031%
8/15/2024	Blue Owl Capital Holdings LP	1,120,027	$5M	1.4%	-11.8%	1.811%
8/15/2024	The Manufacturers Life Insurance Company	21,427	$96K	0.0%	+14.4%	0.035%
8/15/2024	Millennium Management LLC	1,787,947	$7.97M	0.0%	+154.1%	2.890%
8/15/2024	Deerfield Management Company L.P. Series C	11,591	$52K	0.0%	N/A	0.019%
8/15/2024	AQR Capital Management LLC	10,807	$48K	0.0%	-61.0%	0.017%
8/15/2024	Affinity Asset Advisors LLC	2,856,252	$12.74M	1.5%	+8.1%	4.618%
8/14/2024	Cubist Systematic Strategies LLC	18,891	$84K	0.0%	N/A	0.031%
8/14/2024	Samlyn Capital LLC	3,350,535	$14.94M	0.2%	+15.0%	5.417%
8/9/2024	Renaissance Technologies LLC	187,839	$0.84M	0.0%	+8.1%	0.304%
8/9/2024	Dimensional Fund Advisors LP	380,064	$1.70M	0.0%	+117.6%	0.614%
8/8/2024	Meeder Asset Management Inc.	15,210	$68K	0.0%	N/A	0.025%
8/8/2024	American Century Companies Inc.	57,100	$0.26M	0.0%	+11.0%	0.092%
8/1/2024	Rhumbline Advisers	77,004	$0.34M	0.0%	+22.0%	0.124%
7/26/2024	Bank of New York Mellon Corp	190,896	$0.85M	0.0%	+16.1%	0.309%
7/19/2024	Values First Advisors Inc.	17,067	$76K	0.0%	N/A	0.028%
5/16/2024	California State Teachers Retirement System	4,799	$37K	0.0%	-38.9%	0.008%
5/16/2024	Kennedy Capital Management LLC	437,657	$3.35M	0.1%	+52.2%	0.708%
5/15/2024	Affinity Asset Advisors LLC	2,642,519	$20.24M	2.5%	+40.1%	4.272%
5/10/2024	Vanguard Group Inc.	2,419,020	$18.53M	0.0%	+1.4%	3.911%
5/7/2024	SG Americas Securities LLC	13,926	$0.11M	0.0%	-34.4%	0.023%
5/3/2024	GSA Capital Partners LLP	131,098	$1M	0.1%	-21.5%	0.212%
2/20/2024	Eventide Asset Management LLC	3,179,837	$13.55M	0.2%	+1.8%	5.149%
2/15/2024	Octagon Capital Advisors LP	400,000	$1.70M	0.3%	-69.2%	0.648%
2/14/2024	Superstring Capital Management LP	123,944	$0.53M	0.4%	N/A	0.201%
2/13/2024	Affinity Asset Advisors LLC	1,885,802	$8.03M	1.5%	+36.7%	3.053%
1/19/2024	Denali Advisors LLC	22,000	$94K	0.0%	-17.6%	0.036%
1/18/2024	Values First Advisors Inc.	13,898	$59K	0.0%	N/A	0.023%
1/12/2024	SG Americas Securities LLC	21,236	$90K	0.0%	+46.9%	0.034%
11/15/2023	Rock Springs Capital Management LP	3,681,174	$15.46M	0.4%	+7.4%	5.960%
11/15/2023	Laurion Capital Management LP	677,329	$2.85M	0.0%	+170.5%	1.097%
11/15/2023	Adage Capital Partners GP L.L.C.	5,537,500	$23.26M	0.1%	+30.3%	8.966%
11/15/2023	Affinity Asset Advisors LLC	1,379,852	$5.80M	1.6%	+83.5%	2.234%
11/14/2023	Eventide Asset Management LLC	3,125,000	$13.13M	0.2%	N/A	5.060%
11/14/2023	Schonfeld Strategic Advisors LLC	311,880	$1.31M	0.0%	+346.8%	0.505%
11/14/2023	Pivotal bioVenture Partners Investment Advisor LLC	4,494,851	$18.88M	7.5%	+22.8%	7.278%
11/13/2023	CHI Advisors LLC	1,270,027	$5.33M	1.6%	+6.3%	2.056%
11/13/2023	FMR LLC	2,465,232	$10.35M	0.0%	+229.2%	3.992%
11/7/2023	New York State Common Retirement Fund	13,375	$56K	0.0%	-21.8%	0.022%
10/26/2023	Strs Ohio	9,900	$41K	0.0%	N/A	0.016%
10/13/2023	SG Americas Securities LLC	14,452	$61K	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	10,205	$56K	0.0%	+62.7%	0.017%

Data available starting January 2016

See Full Table

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $0.88

$0.87

$0.93

50 Day Range

MA: $1.22

$0.91

$1.52

52 Week Range

Now: $0.88

$0.87

$7.31

Volume

343,585 shs

Average Volume

705,305 shs

Market Capitalization

$56.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Inozyme Pharma?: Inozyme Pharma's top insider investors include:
Robert Lorne Hopfner (Director)
Pivotal Bioventure Partners Fu (Director)
Douglas A Treco (CEO)
Learn More about top insider investors at Inozyme Pharma.
Who are the major institutional investors of Inozyme Pharma?: Inozyme Pharma's top institutional investors include:
Adage Capital Partners GP L.L.C. — 8.03%
Affinity Asset Advisors LLC — 6.18%
Rock Springs Capital Management LP — 6.01%
Millennium Management LLC — 2.93%
Geode Capital Management LLC — 1.84%
Blue Owl Capital Holdings LP — 1.68%
Learn More about top institutional investors of Inozyme Pharma stock.
Which institutional investors are selling Inozyme Pharma stock?: Within the previous quarter, INZY stock was sold by these institutional investors:
Adage Capital Partners GP L.L.C.
Wellington Management Group LLP
Wellington Management Group LLP
Blue Owl Capital Holdings LP
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC
Bank of America Corp DE
Citadel Advisors LLC
Which institutional investors are buying Inozyme Pharma stock?: Within the previous quarter, INZY stock was bought by institutional investors including:
Affinity Asset Advisors LLC
Sanofi
Renaissance Technologies LLC
Walleye Capital LLC
abrdn plc
Millennium Management LLC
Knott David M Jr
Jacobs Levy Equity Management Inc.
In the previous year, these company insiders have bought Inozyme Pharma stock:
Robert Lorne Hopfner (Director)
Pivotal Bioventure Partners Fu (Director)
Learn More investors buying Inozyme Pharma stock.